Health Canada
- Status: approved
Calcipotriol plus betamethasone dipropionate ointment (Calcipotriol plus betamethasone dipropionate ointment) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
LEO Pharma is the originator. The local marketing authorisation holder may differ — check the official source linked above.